University of Pennsylvania: Infections trials

The registry lists 10 Infections studies with University of Pennsylvania as lead sponsor. 1 are open to participants now and 4 have results posted.

Phase 1 1Phase 2 2Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Remote Sputum Collection in Cystic FibrosisRecruitingNCT06950892
• Penn Microbiome Therapy for Recurrent Clostridium Difficile InfectionTerminatedNCT03973697Phase 2Results posted
• Penn Microbiome Therapy (PMT) for Severe-Clostridium Difficile Infection (CDI)TerminatedNCT03970200Phase 2Results posted
• Administration of Zepatier (Grazoprevir Plus Elbasvir) in Chronic Hemodialysis (HD) Patients With Hepatitis CCompletedNCT03365635Phase 4Results posted
• Short-course Methenamine Hippurate for Prevention of Post-operative UTICompletedNCT02358993Not applicableResults posted
• PENNVAX-B With or Without IL-12 or IL-15 as a DNA Vaccine for HIV InfectionCompletedNCT00775424Phase 1
• HIV and STD Prevention for High-Risk, Inner-City, African American YouthCompletedNCT00353405Phase 3
• Human Papillomavirus (HPV) Infection in PregnancyCompletedNCT00194311
• Cytomegalovirus (CMV) Infection in PregnancyCompletedNCT00194155
• Cytomegalovirus (CMV) Infection in Amniotic FluidCompletedNCT00194142